Thomas Hamilton, PhD
Specialty in Diseases & Conditions
- Inflammatory Gene Expression
- Macrophage-Activation Syndrome
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Thomas Hamilton, PhD
Thomas Alan Hamilton, PhD, is a Professor in the Department of Molecular Medicine at Cleveland Clinic Lerner College of Medicine, at Case Western Reserve University. He has held this position since 2003. In addition, he is a Professor with the Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University School of Medicine. Dr. Hamilton also has held positions at many prestigious institutions, including Stanford University, St. Jude Children’s Research Hospital and Duke University Medical Center.
His clinical research interests include: Regulation of Inducible Gene Expression in Mononuclear Phagocytes, Regulation of Chemoattractant Cytokine Expression in Tissue Inflammation and Chemokine Function. His research has been published in leading peer-reviewed journals and he has contributed chapters to medical textbooks in his field. He has been the editor-in-chief, Journal of Interferon and Cytokine Research since 2002. In addition, Dr. Hamilton is an international speaker and presenter.
In 1971, Dr. Hamilton received his BA in Biology/Chemistry at the University of Colorado. He went on to earn his PhD in Biochemistry in 1976 at University of Oregon Health Sciences Center, in Portland. Dr. Hamilton completed several fellowships during this time, including a National Institutes of Health pre-doctoral fellowship in Biochemistry at University of Oregon Health Sciences Center, in Portland, Oregon, and also a NRSA-postdoctoral traineeship in tumor biology, Department of Pathology at Stanford University Medical School, Stanford, California (1976-1978).
Dr. Hamilton is a member of numerous professional associations, including the American Association of Immunologists (Chair, Program Block on NK cells and Macrophages 1996-1999); American Association for Advancement of Science; Society for Leukocyte Biology (Nominating Committee – 1991, Councilor 1992 – 1995, Treasurer 1995-1998; President Elect – 1998; President – 1999; International Society for IFN Research; Secretary 2006-2009); and the International Cytokine Society, among others.
Education & Professional Highlights
Appointed
1987
Education & Fellowships
Medical Education - Oregon Health & Science University
Portland,
OR
1976
Undergraduate - University of Colorado Health Sciences Center
Denver,
CO
1971
Fellowship - Duke University School of Medicine
Durham,
NC
Fellowship - Stanford University
Palo Alto,
CA
Awards & Honors
- Current NIH funding: RO1 CA39621-25, PO1 CA62220
Research & Publications
See publications for Thomas Hamilton, PhD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/1/2024, Dr. Hamilton has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
